Triamcinolone Acetonide NDC 24470-922

NDC codes

FDA NDC Directory

Product NDC (as listed)24470-922Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24470-0922Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24470-922-15	24470092215	430 g in 1 JAR (24470-922-15)Marketed from Nov 10, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamcinolone Acetonide
Generic name (nonproprietary): triamcinolone acetonide
Active ingredients: Triamcinolone acetonide — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Cintex Services, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213619
Marketing start: Nov 10, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 24470-922_b490c63a-9732-eb3a-e053-2a95a90a23f7SPL ID b490c63a-9732-eb3a-e053-2a95a90a23f7SPL set ID be0270a4-5596-499e-aea2-8e63b3edc852RxCUI 1090641UNII F446C597KAUPC 0324470922151
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424470092215 followed by a unit qualifier and the quantity

Package 24470-0922-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 20, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Triamcinolone Acetonide Ointment, USP 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)